News
🌏 NMPA Page 17Latest pharmaceutical news, drug approvals, and NMPA regulatory updates
Showing 193–204 of 238 articles
ACT Genomics Expands Cancer Genomic Testing Panel to 101 Genes with 7-Day Turnaround Time
Qdenga Dengue Vaccine Approved in Australia for Ages 4+ Against All Four Virus Serotypes
Zai Lab's ZL-1503 Bispecific Antibody Shows Promise for Rapid Itch Relief in Atopic Diseases
Antengene Presents Three Novel Cancer Programs at AACR 2026: Next-Generation ADC and TCE Therapies Show Promise
Antengene Presents Next-Generation ADC and AnTenGager TCE Programs at AACR 2026
Australia's TGA Expands Therapeutic Vaping Access Through Pharmacy Channels with New Regulatory Framework
TGA Updates Medical Device Regulations for AI and Software-Based Therapeutic Products in Australia
Atara Biotherapeutics Class Action Lawsuit Filed: ATRA Stockholders May Recover Investment Losses from May 2024-January 2026
Sanyou AI-STAL 2.0 Reduces Antibody Discovery Time from Months to 14 Days in Drug Development Breakthrough
Gene Expression Analysis Market Reaches $5.93 Billion by 2031, Driving Drug Discovery Innovation
Perceptive Discovery Partners with MH3D to Launch α-Sight™ Alpha Radiopharmaceutical Imaging Platform
P&G Health Launches First APAC Pharmacist Guidelines for Peripheral Neuropathy Management